U.S. flag

An official website of the United States government

NM_000251.3(MSH2):c.499G>C (p.Asp167His) AND Hereditary cancer-predisposing syndrome

Germline classification:
Conflicting interpretations of pathogenicity (4 submissions)
Last evaluated:
Jan 2, 2022
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000115533.19

Allele description [Variation Report for NM_000251.3(MSH2):c.499G>C (p.Asp167His)]

NM_000251.3(MSH2):c.499G>C (p.Asp167His)

Gene:
MSH2:mutS homolog 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p21
Genomic location:
Preferred name:
NM_000251.3(MSH2):c.499G>C (p.Asp167His)
Other names:
p.D167H:GAT>CAT
HGVS:
  • NC_000002.12:g.47410226G>C
  • NG_007110.2:g.12103G>C
  • NM_000251.3:c.499G>CMANE SELECT
  • NM_001258281.1:c.301G>C
  • NP_000242.1:p.Asp167His
  • NP_000242.1:p.Asp167His
  • NP_001245210.1:p.Asp101His
  • LRG_218t1:c.499G>C
  • LRG_218:g.12103G>C
  • LRG_218p1:p.Asp167His
  • NC_000002.11:g.47637365G>C
  • NM_000251.1:c.499G>C
  • NM_000251.2:c.499G>C
  • P43246:p.Asp167His
  • p.D167H
Protein change:
D101H
Links:
UniProtKB: P43246#VAR_004474; dbSNP: rs63750255
NCBI 1000 Genomes Browser:
rs63750255
Molecular consequence:
  • NM_000251.3:c.499G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001258281.1:c.301G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000212799Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely benign
(Apr 16, 2018)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Citation Link,

SCV000690113Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely benign
(Jan 2, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000822054GeneKor MSA
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Aug 1, 2018)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002534526Sema4, Sema4
criteria provided, single submitter

(Sema4 Curation Guidelines)
Benign
(Jan 26, 2021)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation

Citations

PubMed

Functional characterization of pathogenic human MSH2 missense mutations in Saccharomyces cerevisiae.

Gammie AE, Erdeniz N, Beaver J, Devlin B, Nanji A, Rose MD.

Genetics. 2007 Oct;177(2):707-21. Epub 2007 Aug 24.

PubMed [citation]
PMID:
17720936
PMCID:
PMC2034637

Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR).

Chao EC, Velasquez JL, Witherspoon MS, Rozek LS, Peel D, Ng P, Gruber SB, Watson P, Rennert G, Anton-Culver H, Lynch H, Lipkin SM.

Hum Mutat. 2008 Jun;29(6):852-60. doi: 10.1002/humu.20735.

PubMed [citation]
PMID:
18383312
See all PubMed Citations (7)

Details of each submission

From Ambry Genetics, SCV000212799.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Color Diagnostics, LLC DBA Color Health, SCV000690113.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From GeneKor MSA, SCV000822054.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Sema4, Sema4, SCV002534526.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024